Clinical trials for Fibrolamellar hepatocellular carcinoma
7 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT06789198Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACAUniversity Hospital Tuebingen
- RECRUITINGPHASE1, PHASE2NCT06620302Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaChildren's Oncology Group · PI: Michael V Ortiz
- RECRUITINGPHASE1, PHASE2NCT06027086DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · PI: Marina Baretti, MD
- RECRUITINGPhase 1NCT05937295FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint InhibitionUniversity Hospital Tuebingen · PI: Salih, Prof. Dr.
- RECRUITINGPHASE1, PHASE2NCT05468359Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor PatientsSt. Jude Children's Research Hospital · PI: Jessica Gartrell, MD
- RECRUITINGPHASE1, PHASE2NCT04380545Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar CancerM.D. Anderson Cancer Center · PI: Sunyoung Lee
- RECRUITINGPhase 2NCT04134559Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaAllison O'Neill, MD · PI: Allison O'Neill, MD